February 4, 2023 Comments Off on New patent for Salix Pharms drug XIFAXAN Posted in: Patent Added Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in one NDA. It is available from two suppliers. There are twenty-seven patents…
The post New patent for Salix Pharms drug XIFAXAN appeared first on Dr…
February 4, 2023 Comments Off on New patent expiration for Endo Pharms drug OPANA ER Posted in: Uncategorized
Annual Drug Patent Expirations for OPANA+ER Opana Er is a drug marketed by Endo Pharms and is included in two NDAs. There are eleven patents protecting this drug and six…
The post New patent expiration for Endo Pharms drug OPANA ER appeared first on Dr…
